Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2026 on February 5
Cardinal Health (NYSE: CAH) will report second-quarter fiscal 2026 results on February 5, 2026, prior to the opening of trading on the New York Stock Exchange.
Cardinal Health (NYSE: CAH) will report second-quarter fiscal 2026 results on February 5, 2026, prior to the opening of trading on the New York Stock Exchange. The company will host a webcast discussion beginning at 8:30 a.m. Eastern.
Investors can access the live webcast and slide presentation through Cardinal Health's Investor Relations page with no access code required. Presentation slides and a replay will remain available on the Investor Relations page for 12 months.
In the Jan 6 session, CAH gained 1.47%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Market Context
This announcement sets the timing for Cardinal Health’s Q2 FY2026 results on February 5, with a webc...
Analysis
This announcement sets the timing for Cardinal Health’s Q2 FY2026 results on February 5, with a webcast at 8:30 a.m. Eastern. In context, the company recently delivered strong Q1 FY2026 growth, raised non‑GAAP EPS and free cash flow guidance, and initiated a $375 million accelerated share repurchase. Investors may watch for updates versus the $9.65–$9.85 EPS outlook, integration of Solaris Health, and any use of the effective S-3ASR shelf registration.
Key Figures
Q1 FY2026 Revenue:$64.0 billionGAAP Operating Earnings:$668 millionGAAP Diluted EPS:$1.88+5 more
Q1 FY2026 Revenue
$64.0 billion
Q1 FY2026 results
GAAP Operating Earnings
$668 million
Q1 FY2026, +18% year-over-year
GAAP Diluted EPS
$1.88
Q1 FY2026, +11% year-over-year
Non-GAAP Operating Earnings
$857 million
Q1 FY2026, +37% year-over-year
Non-GAAP Diluted EPS
$2.55
Q1 FY2026, +36% year-over-year
FY2026 EPS Guidance
$9.65–$9.85
Raised non-GAAP EPS outlook, +17%–20%
Adj. Free Cash Flow
$3.0–$3.5 billion
Raised FY2026 guidance range
ASR Program Size
$375 million
Accelerated share repurchase initiated with Q1 FY2026 results
Scheduled Q1 FY2026 results release and webcast details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Jargon Translator
accelerated share repurchase
An accelerated share repurchase is a deal where a company hires a bank to buy back a large block of its own stock immediately on the open market, with the bank later settling the exact number of shares over time. For investors it matters because the immediate reduction in shares outstanding can raise per‑share earnings and often supports the stock price, but it also uses company cash or borrowing and can change liquidity and future growth funding.
form 4
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Form S-3
Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.
restricted share units
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
shelf prospectus
A shelf prospectus is a regulatory filing that pre-approves a company’s plan to sell shares or bonds over time without needing a new registration each time. Think of it as a menu the company files with regulators that lets it quickly “take items off the shelf” and raise money when market conditions are favorable. Investors care because it signals the company can issue new securities on short notice, which can affect ownership dilution and share price.
DUBLIN, Ohio, Jan. 6, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2026 on February 5, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.
About Cardinal Health Cardinal Health is a distributor of pharmaceuticals and specialty products; a supplier of home-health and direct-to-patient products and services; an operator of nuclear pharmacies and manufacturing facilities; a provider of performance and data solutions; and a global manufacturer and distributor of medical and laboratory products. Our company's customer-centric focus drives continuous improvement and leads to innovative solutions that improve people's lives every day. Learn more about Cardinal Health at cardinalhealth.com and in our Newsroom.
View original content to download multimedia:https://www.prnewswire.com/news-releases/cardinal-health-to-announce-second-quarter-results-for-fiscal-year-2026-on-february-5-302652902.html